Engineers Gate Manager’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,354
Closed -$43.1K 2267
2025
Q4
$43.1K Buy
+10,354
New +$58.8K ﹤0.01% 1989
2024
Q1
Sell
-1,023
Closed -$11.2K 2005
2023
Q4
$11.2K Hold
1,023
﹤0.01% 1922
2023
Q3
$10.5K Hold
1,023
﹤0.01% 1727
2023
Q2
$16.1K Buy
1,023
+201
+24% +$4.6K ﹤0.01% 1668
2023
Q1
$18.6K Sell
822
-191
-19% -$6.29K ﹤0.01% 1593
2022
Q4
$36.2K Buy
1,013
+50
+5% +$1.98K ﹤0.01% 1571
2022
Q3
$38K Sell
963
-358
-27% -$17K ﹤0.01% 1517
2022
Q2
$63K Buy
+1,321
New +$77.5K ﹤0.01% 1779

Other funds holding DTIL

Engineers Gate Manager's DTIL Position: Q1 2026 in Review

Engineers Gate Manager sold out of Precision BioSciences (DTIL) in Q1 2026, closing a stake of 10,354 shares — an estimated $43.1K sold.

Engineers Gate Manager first reported a position in DTIL in Q2 2022 and held it in 8 quarters. The position peaked at $63K in Q2 2022. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Engineers Gate Manager reported no remaining Precision BioSciences position as of Q1 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 10,354 Precision BioSciences shares in Q1 2026, an estimated $43.1K.
  • Engineers Gate Manager first reported a position in Precision BioSciences in Q2 2022 and held it in 8 quarters.
  • Engineers Gate Manager's Precision BioSciences position peaked at $63K in Q2 2022.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.